Personas / Equipo Humano

Marçal Pastor-Anglada

Buscador de publicaciones

Publicaciones

  • Minuesa G, Arimany-Nardi C, Erkizia I, Cedeño S, Moltó J, Clotet B, Pastor-Anglada M and Martinez-Picado J.

    P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(10): 2782-2792. Nº de citas: 20

    [doi:10.1093/jac/dkw215]

  • Perez-Torras S, Iglesias I, Llopis M, Lozano JJ, Antolín M, Guarner F and Pastor-Anglada M.

    Transportome Profiling Identifies Profound Alterations in Crohn's Disease Partially Restored by Commensal Bacteria

    JOURNAL OF CROHNS & COLITIS . 10(7): 850-859. Nº de citas: 19

    [doi:10.1093/ecco-jcc/jjw042]

  • Fernández-Calotti P, Casulleras-Gras O, Antolin M, Guarner F and Pastor-Anglada M.

    Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function

    FASEB JOURNAL . 30(2): 544-554. Nº de citas: 11

    [doi:10.1096/fj.15-272773]

  • Kretschmar C, Oyarzún C, Villablanca C, Jaramillo C, Alarcón S, Perez G, Díaz-Encarnación MM, Pastor-Anglada M, Garrido W, Quezada C and San Martín R.

    Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy

    PLoS One . 11(1): . Nº de citas: 30

    [doi:10.1371/journal.pone.0147430]

  • Veyhl-Wichmann M, Friedrich A, Vernaleken A, Singh S, Kipp H, Gorboulev V, Keller T, Chintalapati C, Pipkorn R, Pastor-Anglada M, Groll J and Koepsell H.

    Phosphorylation of RS1 (RSC1A1) Steers Inhibition of Different Exocytotic Pathways for Glucose Transporter SGLT1 and Nucleoside Transporter CNT1, and an RS1-Derived Peptide Inhibits Glucose Absorption

    MOLECULAR PHARMACOLOGY . 89(1): 118-132. Nº de citas: 22

    [doi:10.1124/mol.115.101162]

  • Arimany-Nardi C, Minuesa G, Keller T, Erkizia I, Koepsell H, Martinez-Picado J and Pastor-Anglada M.

    Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.

    FRONTIERS IN PHARMACOLOGY . 7: 175-175. Nº de citas: 16

    [doi:10.3389/fphar.2016.00175]

  • Arimany-Nardi C, Koepsell H and Pastor-Anglada M.

    Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions

    PHARMACOGENOMICS JOURNAL . 15(6): 473-487. Nº de citas: 28

    [doi:10.1038/tpj.2015.78]

  • Arimany-Nardi C, Montraveta A, Lee-Vergés E, Puente XS, Koepsell H, Campo E, Colomer D and Pastor-Anglada M.

    Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells

    PHARMACOGENOMICS JOURNAL . 15(4): 363-371. Nº de citas: 16

    [doi:10.1038/tpj.2014.77]

  • Claudio-Montero A, Pinilla-Macua I, Fernández-Calotti P, Sancho-Mateo C, Lostao MP, Colomer D, Grandas A and Pastor-Anglada M.

    Fluorescent Nucleoside Derivatives as a Tool for the Detection of Concentrative Nucleoside Transporter Activity Using Confocal Microscopy and Flow Cytometry

    MOLECULAR PHARMACEUTICS . 12(6): 2158-2166. Nº de citas: 6

    [doi:10.1021/acs.molpharmaceut.5b00142]

  • Minami K, Shinsato Y, Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara K, Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Perez-Torras S, Pastor-Anglada M, Furukawa T and Yasuo T.

    Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors

    JOURNAL OF PHARMACOLOGICAL SCIENCES . 127(3): 319-325. Nº de citas: 44

    [doi:10.1016/j.jphs.2015.01.006]